Anavex Life Sciences (AVXL) Treasury Shares (2013 - 2022)
Anavex Life Sciences (AVXL) posted Treasury Shares of $160000.0 for Q3 2022, little changed sequentially from $160000.0 in Q2 2022, and down 23.81% YoY from $210000.0 in Q3 2021.
Anavex Life Sciences (AVXL) Treasury Shares (2013 - 2022) Analysis & Trends
Anavex Life Sciences has reported Treasury Shares for 10 years, with the latest figure at $160000.0 in Q3 2022.
- Quarterly Treasury Shares fell 23.81% year-over-year to $160000.0 in Q3 2022, while the trailing twelve-month figure through Sep 2022 was $160000.0 (down 23.81% YoY) and the FY2022 annual result came in at $160000.0, down 23.81% from the prior year.
- Treasury Shares held at $160000.0 in Q3 2022 per AVXL's latest filing, from $160000.0 in the prior quarter.
- Over five years, Treasury Shares peaked at $1.6 million in Q1 2018 and troughed at $160000.0 in Q4 2021.
- A 5-year average of $510217.2 and a median of $500000.0 in 2019 frame the typical range for Treasury Shares.
- The sharpest annual moves came in 2019 and 2020: Treasury Shares plunged 77.52% in 2019, then soared 42.86% in 2020.
- Over 5 years, Treasury Shares stood at $678379.0 in 2018, then declined by 26.29% to $500000.0 in 2019, then changed by 0.0% to $500000.0 in 2020, then tumbled by 68.0% to $160000.0 in 2021, then changed by 0.0% to $160000.0 in 2022.
- According to Business Quant data, Treasury Shares over the past three periods registered $160000.0, $160000.0, and $160000.0 for Q3 2022, Q2 2022, and Q1 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.08 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 92,219.00 |
| 10 | Anavex Life Sciences | 298.40 Mn | 166.65 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 160,000.00 |
| Sep 30, 2022 | 160,000.00 |
| Jun 30, 2022 | 160,000.00 |
| Jun 30, 2022 | 160,000.00 |
| Mar 31, 2022 | 160,000.00 |
| Mar 31, 2022 | 160,000.00 |
| Dec 31, 2021 | 160,000.00 |
| Dec 31, 2021 | 160,000.00 |
| Sep 30, 2021 | 210,000.00 |
| Sep 30, 2021 | 210,000.00 |
| Jun 30, 2021 | 210,000.00 |
| Jun 30, 2021 | 210,000.00 |
| Mar 31, 2021 | 500,000.00 |
| Mar 31, 2021 | 500,000.00 |
| Dec 31, 2020 | 500,000.00 |
| Dec 31, 2020 | 500,000.00 |
| Sep 30, 2020 | 500,000.00 |
| Sep 30, 2020 | 500,000.00 |
| Jun 30, 2020 | 500,000.00 |
| Jun 30, 2020 | 500,000.00 |